 | • レポートコード：MRC23Q37411 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のブドウ糖＆塩化ナトリウム注射液市場について調査・分析し、世界のブドウ糖＆塩化ナトリウム注射液市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（100ml：ブドウ糖10g、塩化ナトリウム0.9g、250ml：ブドウ糖12.5g、塩化ナトリウム2.25g、500ml：ブドウ糖25g、塩化ナトリウム4.5g、その他）、用途別セグメント分析（病院、クリニック、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Sichuan Kelun Pharmaceutical Co.,Ltd.、Hangzhou Minsheng Pharmaceutical Co., Ltd.、Jiangsu Hengrui Pharmaceuticals Co.,ltd.、SSY Group Limited、Jiangsu Sihuan Bioengineering Co.,Ltd.、China Resources Double-crane Pharmaceutical Co.,Ltd.、Sichuan Biokin Pharmaceutical Co.,Ltd.、Anhui Fengyuan Pharmaceutical Co.,Ltd.、Cisen Pharmaceutical、Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.、Anhui Changjiang Pharmaceutical Co., Ltd.、PKU HealthCare Corp.,Ltd.、CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.、Hebei TIANCHENG Pharmaceutical Co., Ltd.、Southwest Pharmaceutical Co., Ltd.、Pfizer、Amphastar、AstraZeneca plc.、Fresenius Kabi、Baxter、Otsuka Pharmaceutical、Novartis、BBraunなどが含まれています。世界のブドウ糖＆塩化ナトリウム注射液市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ブドウ糖＆塩化ナトリウム注射液市場規模を推定する際に考慮しました。本レポートは、ブドウ糖＆塩化ナトリウム注射液の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ブドウ糖＆塩化ナトリウム注射液に関するビジネス上の意思決定に役立てることを目的としています。 ・ブドウ糖＆塩化ナトリウム注射液市場の概要 - 製品の定義 - ブドウ糖＆塩化ナトリウム注射液のタイプ別セグメント - 世界のブドウ糖＆塩化ナトリウム注射液市場規模：タイプ別分析（100ml：ブドウ糖10g、塩化ナトリウム0.9g、250ml：ブドウ糖12.5g、塩化ナトリウム2.25g、500ml：ブドウ糖25g、塩化ナトリウム4.5g、その他） - ブドウ糖＆塩化ナトリウム注射液の用途別セグメント - 世界のブドウ糖＆塩化ナトリウム注射液市場規模：用途別分析（病院、クリニック、その他） - 世界のブドウ糖＆塩化ナトリウム注射液市場規模予測（2018年-2029年） - ブドウ糖＆塩化ナトリウム注射液の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - ブドウ糖＆塩化ナトリウム注射液市場の競争状況およびトレンド ・ブドウ糖＆塩化ナトリウム注射液の地域別市場規模 - 北米のブドウ糖＆塩化ナトリウム注射液市場規模（2018年-2029年） - アメリカのブドウ糖＆塩化ナトリウム注射液市場規模（2018年-2029年） - ヨーロッパのブドウ糖＆塩化ナトリウム注射液市場規模（2018年-2029年） - アジア太平洋のブドウ糖＆塩化ナトリウム注射液市場規模（2018年-2029年） - 中国のブドウ糖＆塩化ナトリウム注射液市場規模（2018年-2029年） - 日本のブドウ糖＆塩化ナトリウム注射液市場規模（2018年-2029年） - 韓国のブドウ糖＆塩化ナトリウム注射液市場規模（2018年-2029年） - インドのブドウ糖＆塩化ナトリウム注射液市場規模（2018年-2029年） - オーストラリアのブドウ糖＆塩化ナトリウム注射液市場規模（2018年-2029年） - 中南米のブドウ糖＆塩化ナトリウム注射液市場規模（2018年-2029年） - 中東・アフリカのブドウ糖＆塩化ナトリウム注射液市場規模（2018年-2029年） ・タイプ別セグメント：100ml：ブドウ糖10g、塩化ナトリウム0.9g、250ml：ブドウ糖12.5g、塩化ナトリウム2.25g、500ml：ブドウ糖25g、塩化ナトリウム4.5g、その他 - 世界のブドウ糖＆塩化ナトリウム注射液のタイプ別販売量（2018年-2023年） - 世界のブドウ糖＆塩化ナトリウム注射液のタイプ別売上（2018年-2023年） - 世界のブドウ糖＆塩化ナトリウム注射液のタイプ別価格 ・用途別セグメント：病院、クリニック、その他 - 世界のブドウ糖＆塩化ナトリウム注射液の用途別販売量（2018年-2023年） - 世界のブドウ糖＆塩化ナトリウム注射液の用途別売上（2018年-2023年） - 世界のブドウ糖＆塩化ナトリウム注射液の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Sichuan Kelun Pharmaceutical Co.,Ltd.、Hangzhou Minsheng Pharmaceutical Co., Ltd.、Jiangsu Hengrui Pharmaceuticals Co.,ltd.、SSY Group Limited、Jiangsu Sihuan Bioengineering Co.,Ltd.、China Resources Double-crane Pharmaceutical Co.,Ltd.、Sichuan Biokin Pharmaceutical Co.,Ltd.、Anhui Fengyuan Pharmaceutical Co.,Ltd.、Cisen Pharmaceutical、Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.、Anhui Changjiang Pharmaceutical Co., Ltd.、PKU HealthCare Corp.,Ltd.、CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.、Hebei TIANCHENG Pharmaceutical Co., Ltd.、Southwest Pharmaceutical Co., Ltd.、Pfizer、Amphastar、AstraZeneca plc.、Fresenius Kabi、Baxter、Otsuka Pharmaceutical、Novartis、BBraun ・産業チェーンと販売チャネルの分析 - ブドウ糖＆塩化ナトリウム注射液産業チェーン分析 - ブドウ糖＆塩化ナトリウム注射液の主要原材料 - ブドウ糖＆塩化ナトリウム注射液の販売チャネル - ブドウ糖＆塩化ナトリウム注射液のディストリビューター - ブドウ糖＆塩化ナトリウム注射液の主要顧客 ・ブドウ糖＆塩化ナトリウム注射液市場ダイナミクス - ブドウ糖＆塩化ナトリウム注射液の業界動向 - ブドウ糖＆塩化ナトリウム注射液市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Glucose Sodium Chloride Injection is a compound preparation, corresponding to different contents of glucose and sodium chloride according to the specification. It is used to supplement heat energy and body fluids, as well as lack of food or loss of a large amount of body fluids caused by various reasons. Its side effects can cause hypernatremia and hypokalemia, and can cause bicarbonate loss.
Highlights
The global Glucose and Sodium Chloride Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Glucose and Sodium Chloride Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Glucose and Sodium Chloride Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Glucose and Sodium Chloride Injection include Sichuan Kelun Pharmaceutical Co.,Ltd., Hangzhou Minsheng Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd., SSY Group Limited, Jiangsu Sihuan Bioengineering Co.,Ltd., China Resources Double-crane Pharmaceutical Co.,Ltd., Sichuan Biokin Pharmaceutical Co.,Ltd., Anhui Fengyuan Pharmaceutical Co.,Ltd. and Cisen Pharmaceutical, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Glucose and Sodium Chloride Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucose and Sodium Chloride Injection.
The Glucose and Sodium Chloride Injection market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Glucose and Sodium Chloride Injection market comprehensively. Regional market sizes, concerning products by specification, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glucose and Sodium Chloride Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by specification, by application and by regions.
By Company
Sichuan Kelun Pharmaceutical Co.,Ltd.
Hangzhou Minsheng Pharmaceutical Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co.,ltd.
SSY Group Limited
Jiangsu Sihuan Bioengineering Co.,Ltd.
China Resources Double-crane Pharmaceutical Co.,Ltd.
Sichuan Biokin Pharmaceutical Co.,Ltd.
Anhui Fengyuan Pharmaceutical Co.,Ltd.
Cisen Pharmaceutical
Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.
Anhui Changjiang Pharmaceutical Co., Ltd.
PKU HealthCare Corp.,Ltd.
CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
Hebei TIANCHENG Pharmaceutical Co., Ltd.
Southwest Pharmaceutical Co., Ltd.
Pfizer
Amphastar
AstraZeneca plc.
Fresenius Kabi
Baxter
Otsuka Pharmaceutical
Novartis
BBraun
Segment by Specification
100ml: Glucose 10g, Sodium Chloride 0.9g
250ml: Glucose 12.5g and Sodium Chloride 2.25g
500ml: Glucose 25g and Sodium Chloride 4.5g
Other
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glucose and Sodium Chloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glucose and Sodium Chloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by specification, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Glucose and Sodium Chloride Injection Market Overview
1.1 Product Overview and Scope of Glucose and Sodium Chloride Injection
1.2 Glucose and Sodium Chloride Injection Segment by Specification
1.2.1 Global Glucose and Sodium Chloride Injection Market Value Comparison by Specification (2023-2029)
1.2.2 100ml: Glucose 10g, Sodium Chloride 0.9g
1.2.3 250ml: Glucose 12.5g and Sodium Chloride 2.25g
1.2.4 500ml: Glucose 25g and Sodium Chloride 4.5g
1.2.5 Other
1.3 Glucose and Sodium Chloride Injection Segment by Application
1.3.1 Global Glucose and Sodium Chloride Injection Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Glucose and Sodium Chloride Injection Market Size Estimates and Forecasts
1.4.1 Global Glucose and Sodium Chloride Injection Revenue 2018-2029
1.4.2 Global Glucose and Sodium Chloride Injection Sales 2018-2029
1.4.3 Global Glucose and Sodium Chloride Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Glucose and Sodium Chloride Injection Market Competition by Manufacturers
2.1 Global Glucose and Sodium Chloride Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Glucose and Sodium Chloride Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Glucose and Sodium Chloride Injection Average Price by Manufacturers (2018-2023)
2.4 Global Glucose and Sodium Chloride Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Glucose and Sodium Chloride Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glucose and Sodium Chloride Injection, Product Type & Application
2.7 Glucose and Sodium Chloride Injection Market Competitive Situation and Trends
2.7.1 Glucose and Sodium Chloride Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glucose and Sodium Chloride Injection Players Market Share by Revenue
2.7.3 Global Glucose and Sodium Chloride Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glucose and Sodium Chloride Injection Retrospective Market Scenario by Region
3.1 Global Glucose and Sodium Chloride Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Glucose and Sodium Chloride Injection Global Glucose and Sodium Chloride Injection Sales by Region: 2018-2029
3.2.1 Global Glucose and Sodium Chloride Injection Sales by Region: 2018-2023
3.2.2 Global Glucose and Sodium Chloride Injection Sales by Region: 2024-2029
3.3 Global Glucose and Sodium Chloride Injection Global Glucose and Sodium Chloride Injection Revenue by Region: 2018-2029
3.3.1 Global Glucose and Sodium Chloride Injection Revenue by Region: 2018-2023
3.3.2 Global Glucose and Sodium Chloride Injection Revenue by Region: 2024-2029
3.4 North America Glucose and Sodium Chloride Injection Market Facts & Figures by Country
3.4.1 North America Glucose and Sodium Chloride Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Glucose and Sodium Chloride Injection Sales by Country (2018-2029)
3.4.3 North America Glucose and Sodium Chloride Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Glucose and Sodium Chloride Injection Market Facts & Figures by Country
3.5.1 Europe Glucose and Sodium Chloride Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Glucose and Sodium Chloride Injection Sales by Country (2018-2029)
3.5.3 Europe Glucose and Sodium Chloride Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glucose and Sodium Chloride Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Glucose and Sodium Chloride Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Glucose and Sodium Chloride Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Glucose and Sodium Chloride Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Glucose and Sodium Chloride Injection Market Facts & Figures by Country
3.7.1 Latin America Glucose and Sodium Chloride Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Glucose and Sodium Chloride Injection Sales by Country (2018-2029)
3.7.3 Latin America Glucose and Sodium Chloride Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Glucose and Sodium Chloride Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Glucose and Sodium Chloride Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Glucose and Sodium Chloride Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Glucose and Sodium Chloride Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Specification
4.1 Global Glucose and Sodium Chloride Injection Sales by Specification (2018-2029)
4.1.1 Global Glucose and Sodium Chloride Injection Sales by Specification (2018-2023)
4.1.2 Global Glucose and Sodium Chloride Injection Sales by Specification (2024-2029)
4.1.3 Global Glucose and Sodium Chloride Injection Sales Market Share by Specification (2018-2029)
4.2 Global Glucose and Sodium Chloride Injection Revenue by Specification (2018-2029)
4.2.1 Global Glucose and Sodium Chloride Injection Revenue by Specification (2018-2023)
4.2.2 Global Glucose and Sodium Chloride Injection Revenue by Specification (2024-2029)
4.2.3 Global Glucose and Sodium Chloride Injection Revenue Market Share by Specification (2018-2029)
4.3 Global Glucose and Sodium Chloride Injection Price by Specification (2018-2029)
5 Segment by Application
5.1 Global Glucose and Sodium Chloride Injection Sales by Application (2018-2029)
5.1.1 Global Glucose and Sodium Chloride Injection Sales by Application (2018-2023)
5.1.2 Global Glucose and Sodium Chloride Injection Sales by Application (2024-2029)
5.1.3 Global Glucose and Sodium Chloride Injection Sales Market Share by Application (2018-2029)
5.2 Global Glucose and Sodium Chloride Injection Revenue by Application (2018-2029)
5.2.1 Global Glucose and Sodium Chloride Injection Revenue by Application (2018-2023)
5.2.2 Global Glucose and Sodium Chloride Injection Revenue by Application (2024-2029)
5.2.3 Global Glucose and Sodium Chloride Injection Revenue Market Share by Application (2018-2029)
5.3 Global Glucose and Sodium Chloride Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sichuan Kelun Pharmaceutical Co.,Ltd.
6.1.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Corporation Information
6.1.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Description and Business Overview
6.1.3 Sichuan Kelun Pharmaceutical Co.,Ltd. Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sichuan Kelun Pharmaceutical Co.,Ltd. Glucose and Sodium Chloride Injection Product Portfolio
6.1.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.2 Hangzhou Minsheng Pharmaceutical Co., Ltd.
6.2.1 Hangzhou Minsheng Pharmaceutical Co., Ltd. Corporation Information
6.2.2 Hangzhou Minsheng Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Hangzhou Minsheng Pharmaceutical Co., Ltd. Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Hangzhou Minsheng Pharmaceutical Co., Ltd. Glucose and Sodium Chloride Injection Product Portfolio
6.2.5 Hangzhou Minsheng Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
6.3.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Corporation Information
6.3.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Description and Business Overview
6.3.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Glucose and Sodium Chloride Injection Product Portfolio
6.3.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments/Updates
6.4 SSY Group Limited
6.4.1 SSY Group Limited Corporation Information
6.4.2 SSY Group Limited Description and Business Overview
6.4.3 SSY Group Limited Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 SSY Group Limited Glucose and Sodium Chloride Injection Product Portfolio
6.4.5 SSY Group Limited Recent Developments/Updates
6.5 Jiangsu Sihuan Bioengineering Co.,Ltd.
6.5.1 Jiangsu Sihuan Bioengineering Co.,Ltd. Corporation Information
6.5.2 Jiangsu Sihuan Bioengineering Co.,Ltd. Description and Business Overview
6.5.3 Jiangsu Sihuan Bioengineering Co.,Ltd. Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Jiangsu Sihuan Bioengineering Co.,Ltd. Glucose and Sodium Chloride Injection Product Portfolio
6.5.5 Jiangsu Sihuan Bioengineering Co.,Ltd. Recent Developments/Updates
6.6 China Resources Double-crane Pharmaceutical Co.,Ltd.
6.6.1 China Resources Double-crane Pharmaceutical Co.,Ltd. Corporation Information
6.6.2 China Resources Double-crane Pharmaceutical Co.,Ltd. Description and Business Overview
6.6.3 China Resources Double-crane Pharmaceutical Co.,Ltd. Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 China Resources Double-crane Pharmaceutical Co.,Ltd. Glucose and Sodium Chloride Injection Product Portfolio
6.6.5 China Resources Double-crane Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.7 Sichuan Biokin Pharmaceutical Co.,Ltd.
6.6.1 Sichuan Biokin Pharmaceutical Co.,Ltd. Corporation Information
6.6.2 Sichuan Biokin Pharmaceutical Co.,Ltd. Description and Business Overview
6.6.3 Sichuan Biokin Pharmaceutical Co.,Ltd. Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sichuan Biokin Pharmaceutical Co.,Ltd. Glucose and Sodium Chloride Injection Product Portfolio
6.7.5 Sichuan Biokin Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.8 Anhui Fengyuan Pharmaceutical Co.,Ltd.
6.8.1 Anhui Fengyuan Pharmaceutical Co.,Ltd. Corporation Information
6.8.2 Anhui Fengyuan Pharmaceutical Co.,Ltd. Description and Business Overview
6.8.3 Anhui Fengyuan Pharmaceutical Co.,Ltd. Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Anhui Fengyuan Pharmaceutical Co.,Ltd. Glucose and Sodium Chloride Injection Product Portfolio
6.8.5 Anhui Fengyuan Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.9 Cisen Pharmaceutical
6.9.1 Cisen Pharmaceutical Corporation Information
6.9.2 Cisen Pharmaceutical Description and Business Overview
6.9.3 Cisen Pharmaceutical Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cisen Pharmaceutical Glucose and Sodium Chloride Injection Product Portfolio
6.9.5 Cisen Pharmaceutical Recent Developments/Updates
6.10 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.
6.10.1 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. Corporation Information
6.10.2 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. Description and Business Overview
6.10.3 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. Glucose and Sodium Chloride Injection Product Portfolio
6.10.5 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. Recent Developments/Updates
6.11 Anhui Changjiang Pharmaceutical Co., Ltd.
6.11.1 Anhui Changjiang Pharmaceutical Co., Ltd. Corporation Information
6.11.2 Anhui Changjiang Pharmaceutical Co., Ltd. Glucose and Sodium Chloride Injection Description and Business Overview
6.11.3 Anhui Changjiang Pharmaceutical Co., Ltd. Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Anhui Changjiang Pharmaceutical Co., Ltd. Glucose and Sodium Chloride Injection Product Portfolio
6.11.5 Anhui Changjiang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 PKU HealthCare Corp.,Ltd.
6.12.1 PKU HealthCare Corp.,Ltd. Corporation Information
6.12.2 PKU HealthCare Corp.,Ltd. Glucose and Sodium Chloride Injection Description and Business Overview
6.12.3 PKU HealthCare Corp.,Ltd. Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 PKU HealthCare Corp.,Ltd. Glucose and Sodium Chloride Injection Product Portfolio
6.12.5 PKU HealthCare Corp.,Ltd. Recent Developments/Updates
6.13 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
6.13.1 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. Corporation Information
6.13.2 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. Glucose and Sodium Chloride Injection Description and Business Overview
6.13.3 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. Glucose and Sodium Chloride Injection Product Portfolio
6.13.5 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. Recent Developments/Updates
6.14 Hebei TIANCHENG Pharmaceutical Co., Ltd.
6.14.1 Hebei TIANCHENG Pharmaceutical Co., Ltd. Corporation Information
6.14.2 Hebei TIANCHENG Pharmaceutical Co., Ltd. Glucose and Sodium Chloride Injection Description and Business Overview
6.14.3 Hebei TIANCHENG Pharmaceutical Co., Ltd. Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Hebei TIANCHENG Pharmaceutical Co., Ltd. Glucose and Sodium Chloride Injection Product Portfolio
6.14.5 Hebei TIANCHENG Pharmaceutical Co., Ltd. Recent Developments/Updates
6.15 Southwest Pharmaceutical Co., Ltd.
6.15.1 Southwest Pharmaceutical Co., Ltd. Corporation Information
6.15.2 Southwest Pharmaceutical Co., Ltd. Glucose and Sodium Chloride Injection Description and Business Overview
6.15.3 Southwest Pharmaceutical Co., Ltd. Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Southwest Pharmaceutical Co., Ltd. Glucose and Sodium Chloride Injection Product Portfolio
6.15.5 Southwest Pharmaceutical Co., Ltd. Recent Developments/Updates
6.16 Pfizer
6.16.1 Pfizer Corporation Information
6.16.2 Pfizer Glucose and Sodium Chloride Injection Description and Business Overview
6.16.3 Pfizer Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Pfizer Glucose and Sodium Chloride Injection Product Portfolio
6.16.5 Pfizer Recent Developments/Updates
6.17 Amphastar
6.17.1 Amphastar Corporation Information
6.17.2 Amphastar Glucose and Sodium Chloride Injection Description and Business Overview
6.17.3 Amphastar Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Amphastar Glucose and Sodium Chloride Injection Product Portfolio
6.17.5 Amphastar Recent Developments/Updates
6.18 AstraZeneca plc.
6.18.1 AstraZeneca plc. Corporation Information
6.18.2 AstraZeneca plc. Glucose and Sodium Chloride Injection Description and Business Overview
6.18.3 AstraZeneca plc. Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.18.4 AstraZeneca plc. Glucose and Sodium Chloride Injection Product Portfolio
6.18.5 AstraZeneca plc. Recent Developments/Updates
6.19 Fresenius Kabi
6.19.1 Fresenius Kabi Corporation Information
6.19.2 Fresenius Kabi Glucose and Sodium Chloride Injection Description and Business Overview
6.19.3 Fresenius Kabi Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Fresenius Kabi Glucose and Sodium Chloride Injection Product Portfolio
6.19.5 Fresenius Kabi Recent Developments/Updates
6.20 Baxter
6.20.1 Baxter Corporation Information
6.20.2 Baxter Glucose and Sodium Chloride Injection Description and Business Overview
6.20.3 Baxter Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Baxter Glucose and Sodium Chloride Injection Product Portfolio
6.20.5 Baxter Recent Developments/Updates
6.21 Otsuka Pharmaceutical
6.21.1 Otsuka Pharmaceutical Corporation Information
6.21.2 Otsuka Pharmaceutical Glucose and Sodium Chloride Injection Description and Business Overview
6.21.3 Otsuka Pharmaceutical Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Otsuka Pharmaceutical Glucose and Sodium Chloride Injection Product Portfolio
6.21.5 Otsuka Pharmaceutical Recent Developments/Updates
6.22 Novartis
6.22.1 Novartis Corporation Information
6.22.2 Novartis Glucose and Sodium Chloride Injection Description and Business Overview
6.22.3 Novartis Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Novartis Glucose and Sodium Chloride Injection Product Portfolio
6.22.5 Novartis Recent Developments/Updates
6.23 BBraun
6.23.1 BBraun Corporation Information
6.23.2 BBraun Glucose and Sodium Chloride Injection Description and Business Overview
6.23.3 BBraun Glucose and Sodium Chloride Injection Sales, Revenue and Gross Margin (2018-2023)
6.23.4 BBraun Glucose and Sodium Chloride Injection Product Portfolio
6.23.5 BBraun Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glucose and Sodium Chloride Injection Industry Chain Analysis
7.2 Glucose and Sodium Chloride Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glucose and Sodium Chloride Injection Production Mode & Process
7.4 Glucose and Sodium Chloride Injection Sales and Marketing
7.4.1 Glucose and Sodium Chloride Injection Sales Channels
7.4.2 Glucose and Sodium Chloride Injection Distributors
7.5 Glucose and Sodium Chloride Injection Customers
8 Glucose and Sodium Chloride Injection Market Dynamics
8.1 Glucose and Sodium Chloride Injection Industry Trends
8.2 Glucose and Sodium Chloride Injection Market Drivers
8.3 Glucose and Sodium Chloride Injection Market Challenges
8.4 Glucose and Sodium Chloride Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer